person

Inâame E.

Country
France
Department
Anesthésie réanimation et médecine péri-opératoire - AP-HP Kremlin Bicêtre

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 11 partner sites.

Specializations

Peri‑operative Critical Care

Focus on acute respiratory distress syndrome, septic shock, and mechanical ventilation in adult intensive care units.

  • Ventilation strategies for ARDS
  • Hemodynamic optimization in septic shock
  • Post‑operative organ support protocols

Integrates anesthetic expertise with resuscitative techniques to improve peri‑operative outcomes.

Oncology – Solid Tumor Therapeutics

Investigates treatment pathways for non‑small cell lung cancer, colorectal carcinoma, and head and neck squamous cell carcinoma across advanced disease stages.

  • Targeted therapy in NSCLC
  • Immunotherapy combinations for head and neck cancer
  • Neoadjuvant strategies for rectal cancer

Emphasizes translational approaches that bridge surgical oncology and systemic therapy.

Hematology – Blood Malignancies

Addresses clinical challenges in acute myeloid leukemia, multiple myeloma, and chronic lymphocytic leukemia including refractory disease settings.

  • Novel agents for AML relapse
  • Combination regimens in relapsed myeloma
  • Risk‑adapted therapy for CLL

Focuses on optimizing therapeutic sequencing and patient‑centered outcomes.

Cardiovascular – Acute Coronary Syndromes & Heart Failure

Evaluates interventions for acute myocardial infarction, heart failure with reduced ejection fraction, and cardiogenic shock in emergency and critical care environments.

  • Early reperfusion strategies
  • Pharmacologic modulation of post‑MI remodeling
  • Mechanical circulatory support in shock

Integrates rapid diagnostic pathways with evidence‑based therapeutics.

Rare & Metabolic Disorders – Amyloidosis & Genetic Diseases

Specializes in hereditary transthyretin amyloidosis, familial amyloid cardiomyopathy, and metabolic liver diseases affecting multiple organ systems.

  • RNAi‑based silencing therapies
  • Stabilizer compounds for TTR amyloid
  • Clinical management of metabolic hepatopathies

Advances precision medicine for ultra‑rare conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.